In recent years, biopharma and biotech industries have been adopting single-use technologies in cGMP manufacturing more often, making single-use supply strategy absolutely vital. That is why Thermo Fisher Scientific employs a combinatorial strategy that utilizes standardization, global capacity expansion, and quality harmonization processes to help ensure you have consistent access to high-quality products.
Locally supported by Labotec, the Thermo Fisher Scientific standardised modularised manufacturing strategies for single-use technologies has provided a viable option with the promise of reduced costs, flexibility and faster pathways to market by leveraging risky single-source supply chain strategies for design and sourcing of complex, optimised single-use solutions to meet a wide range of process-specific applications.
There are many factors to consider when selecting equipment for a Bioprocessing lab and here are the five main points taken from a white paper you can read the article here download Six Critical considerations for Bioprocess lab equipment selection. They cover these questions and provide the answers on considerations when selecting bioprocess equipment.
Read this article to learn:
- Is there a link between your research, clinical, and commercial manufacturing?
- What is your scale-up and/or tech transfer requirements?
- Is GMP compliance required?
- Are there plans to work with a CDMO?
- How important is it for the data to be in a digital environment?
- How much time and what resources are you willing to invest in training?
Standardised and modularised engineering can benefit manufacturers starting new processes and manufacturers considering converting an existing process.
To evaluate the challenges of implementation, Thermo Fisher Scientific performed a case study of a firm that was able to accomplish this change using minimal non‑dedicated staff. You can read this white paper here; Value of standardisation modularised manufacturing strategies for single-use technologies
